Active Research Protocols
- 04-C-0275 – Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity
- 11-C-0233 – Pilot Study of Tocilizumab in Patients with Symptomatic Kaposi Sarcoma Herpesvirus (KSHV) - Associated Multicentric Castleman Disease
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014